In October 2024, Novartis announced that based on its review of 48-week data from the Phase 3 MANIFEST-2 study, longer follow-up time is needed to determine the regulatory path for pelabresib in ...

Seventh Year in a Row of Approximately 50% or Better Cash Margins Cash Flow Growth Initiatives Contributed Over $50 million in Cash Flow Company Returned Over $105 million to Shareholders in 2024 ...

Paysafe Limited ("Paysafe" or the "Company") (NYSE: PSFE), a leading payments platform, announced a definitive agreement to sell its direct marketing payment processing business line ("the disposed ...

Calibre Mining is pleased to announce additional discovery diamond drill results from its expanded 100,000 metre drill program at the Valentine Gold Mine. Previous drilling highlights the considerable ...